Investigating the effect of Ginko biloba on attention deficit hyperactivity disorder symptoms
Phase 3
Not yet recruiting
- Conditions
- Attention deficit hyperactivity disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20151123025202N31
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age 5 to 15 years
Normal IQ
Exclusion Criteria
patients with neurological or organic disorder
Patients on a special diet
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Ginkgo biloba may influence ADHD symptom improvement in pediatric patients?
How does Ginkgo biloba compare to stimulant medications like methylphenidate in treating ADHD in children aged 5-15?
Are there specific biomarkers that could predict response to Ginkgo biloba treatment in ADHD patients?
What are the potential adverse events associated with Ginkgo biloba in pediatric ADHD populations and how are they managed?
What combination therapies or competitor drugs are being explored alongside Ginkgo biloba for ADHD treatment in clinical research?